Recent studies by Kortam et al. report a downregulation of the PTEN gene expression in the serum of 100 MS patients compared to healthy controls, accompanied by an upregulation of the AKT gene expression [28]. The gene discussed is AKT1; the disease is myeloid sarcoma.